Literature DB >> 2885170

The role of arachidonic acid metabolites in gastrointestinal homeostasis. Biochemical, histological and clinical gastrointestinal effects.

K J Isselbacher.   

Abstract

Metabolites of arachidonic acid have a broad range of physiological functions in the gastrointestinal tract, and seem to be involved in certain disturbances of gastrointestinal integrity and function. Prostaglandins inhibit gastric acid secretion, apparently via an adenylate cyclase-linked receptor, and also stimulate bicarbonate and mucus production by alternative mechanisms. These are all beneficial in treating gastroduodenal ulceration. Moreover, clinical studies have revealed deficient prostaglandin synthesis in the gastric and duodenal mucosa of patients with gastrointestinal ulcers, which suggests that endogenous prostaglandins have a protective role in the gastrointestinal tract. In animal studies, prostaglandin analogues have been shown to protect the gastric mucosa from damage induced by various potent irritants, and this protection seems to involve the deeper layers of the mucosa as well as the epithelium. Indeed, misoprostol and other prostaglandin analogues have proved therapeutically effective in treating gastroduodenal ulceration. Prostaglandins also influence intestinal motility and fluid movement. Prostaglandin E derivatives generally relax circular smooth muscle, contract longitudinal smooth muscle and increase fluid secretion into the intestinal lumen. As a result of these effects, prostaglandins may cause diarrhoea. There is also evidence that prostaglandin synthesis is increased in patients with diarrhoea. Finally, it has been reported that tissue concentrations of prostaglandins are increased in patients with ulcerative colitis, but it is unclear if this is a primary cause, or secondary event. Significantly greater conversion of arachidonic acid to its metabolites was recorded in the mucosa of patients with inflammatory bowel disease compared with the mucosa of healthy subjects. This included a substantial increase in the concentration of leukotriene B4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885170     DOI: 10.2165/00003495-198700331-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  15 in total

1.  Duodenal bicarbonate secretion in humans. Role of prostaglandins.

Authors:  J I Isenberg; D L Hogan; J A Selling; M A Koss
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

2.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

3.  Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.

Authors:  S K Lam; W Y Lau; T K Choi; C L Lai; A S Lok; W M Hui; M M Ng; S K Choi
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

4.  A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.

Authors:  F L Lanza
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

5.  Prevention of aspirin-induced drop in gastric potential difference with 16, 16-dimethyl-prostaglandin E2.

Authors:  P Müller; N Fischer; H Kather; B Simon
Journal:  Lancet       Date:  1981-02-07       Impact factor: 79.321

Review 6.  Prostaglandins and histological changes in the gastric mucosa.

Authors:  E R Lacy
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

7.  Prostanoid synthesis by cultured gastric and duodenal mucosa: Possible role in the pathogenesis of duodenal ulcer.

Authors:  P Sharon; F Cohen; A Zifroni; F Karmeli; M Ligumsky; D Rachmilewitz
Journal:  Scand J Gastroenterol       Date:  1983-11       Impact factor: 2.423

8.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

9.  Comparison of serum salicylate levels and gastro-intestinal blood loss between salsalate (Disalcid)and other forms of salicylates.

Authors:  H Mielants; E M Veys; G Verbruggen
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

10.  Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa.

Authors:  L M Lichtenberger; J E Richards; B A Hills
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  2 in total

Review 1.  Salicylates revisited. Are they still the hallmark of anti-inflammatory therapy?

Authors:  S H Roth
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

2.  Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability.

Authors:  G R Davies; M E Wilkie; D S Rampton
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.